http://www.advfn.com/nasdaq/rss.asp?symbol=ZIOP Ziopharm Oncology Company Newsfeed en Tue, 26 Mar 2013 09:17:58 EDT Tue, 26 Mar 2013 09:17:58 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ZIOP&article=56908763&headline=u-s-hot-stock-futures-hot-stocks-to-watch http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ZIOP&article=56908763&headline=u-s-hot-stock-futures-hot-stocks-to-watch <div class='newsbody'><p> Among the companies with shares expected to actively trade in Tuesday's session are Ziopharm Oncology Inc. (ZIOP), Gordmans Stores Inc. (GMAN) and Calumet Specialty Products Partners L.P. (CLMT). </p> <p> Ziopharm Oncology Inc. (ZIOP) ended development of its cancer drug palifosamide... Tue, 26 Mar 2013 09:17:58 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ZIOP&article=48022104&headline=ziopharm-fda-approves-application-to-test-melanoma-treatment http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ZIOP&article=48022104&headline=ziopharm-fda-approves-application-to-test-melanoma-treatment <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> Ziopharm Oncology Inc. (ZIOP) said the U.S. Food and Drug Administration has accepted its application to begin clinical study of its investigational melanoma gene-based treatment under a partnership with Intrexon Corp. that it formed earlier this... Fri, 10 Jun 2011 07:04:15 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ZIOP&article=47664669&headline=ziopharm-files-investigational-new-drug-application-for-melanoma http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ZIOP&article=47664669&headline=ziopharm-files-investigational-new-drug-application-for-melanoma <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> Ziopharm Oncology Inc. (ZIOP) submitted an investigational new drug application for a product candidate to treat melanoma under its partnership with Intrexon Corp. that was formed this year. </p> <p> Ziopharm, a small-molecule late-stage oncology... Fri, 13 May 2011 07:22:08 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ZIOP&article=44493708&headline=ziopharm-gets-orphan-drug-status-for-lymphoma-drug http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ZIOP&article=44493708&headline=ziopharm-gets-orphan-drug-status-for-lymphoma-drug <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> Ziopharm Oncology Inc.'s (ZIOP) Zinapar got orphan-drug status from the U.S. Food and Drug Administration for a treatment for a group of lymphomas. </p> <p> The designation seeks to promote the development of treatments for diseases that affect fewer... Thu, 23 Sep 2010 07:56:21 EDT